1Institute for Molecular Microbiology and Biotechnology, University of Münster, Corrensstr. 3, 48149 Münster, Germany
2Organic Chemistry Institute, University of Münster, Corrensstr. 40, 48149 Münster, Germany
3Organic Chemistry Research Group, Departments of Chemistry and Bioengineering Sciences, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussel, Belgium
Corresponding author email
Associate Editor: J. S. Dickschat Beilstein J. Org. Chem.2019,15, 187–193.https://doi.org/10.3762/bjoc.15.18 Received 29 Sep 2018,
Accepted 02 Jan 2019,
Published 21 Jan 2019
Selectively methylated analogues of naturally occurring 2-heptyl-4(1H)-quinolones, which are alkaloids common within the Rutaceae family and moreover are associated with quorum sensing and virulence of the human pathogen Pseudomonas aeruginosa, have been prepared. While the synthesis by direct methylation was successful for 3-unsubstituted 2-heptyl-4(1H)-quinolones, methylated derivatives of the Pseudomonas quinolone signal (PQS) were synthesized from 3-iodinated quinolones by methylation and iodine–metal exchange/oxidation. The two N- and O-methylated derivatives of the PQS showed strong quorum sensing activity comparable to that of PQS itself. Staphylococcus aureus, another pathogenic bacterium often co-occurring with P. aeruginosa especially in the lung of cystic fibrosis patients, was inhibited in planktonic growth and cellular respiration by the 4-O-methylated derivatives of HQNO and HHQ, respectively.
2-Alkyl-4(1H)-quinolones (AQs) have been identified as natural products produced by higher plants of the Rutaceae family as well as by some microorganisms including Alteromonas, Burkholderia and Pseudomonas species [1-9]. Plant-derived AQs occur with alkyl chains of different lengths, branches and unsaturation and can be O- or N-methylated [1-3]. In the opportunistic pathogen Pseudomonas aeruginosa, AQ derivatives with heptyl or nonyl side chains are prevalent [3,7-9]. 2-Heptyl-3-hydroxy-4(1H)-quinolone (Pseudomonas quinolone signal, PQS) and its biosynthetic precursor 2-heptyl-4(1H)-quinolone (HHQ, 1) are important signaling molecules involved in quorum sensing and as such play an important role in virulence regulation [3,10-12]. Another metabolite from the AQ biosynthesis pathway of P. aeruginosa is 2-heptyl-1-hydroxy-4(1H)-quinolone (generally referred to as 2-heptyl-4-hydroxyquinoline N-oxide, HQNO), which is not active in quorum sensing, but interferes with the respiratory electron transport via inhibition of the cytochrome bc1 complex and moreover inhibits pyrimidine biosynthesis [9,12-14]. Therefore, HQNO is toxic to many organisms. In dual-species co-cultures of P. aeruginosa and Staphylococcus aureus, which model interactions relevant to patients with cystic fibrosis, HQNO is a major factor for killing of S. aureus[15]. While HQNO seems to be generally toxic to Gram-positive bacteria, we could show that some bacteria are able to transform HQNO into less toxic metabolites [16]. For example, Mycobacterium abscessus, which like P. aeruginosa and S. aureus can occur in the lung of cystic fibrosis patients [17-19], is able to methylate HQNO to give 2-heptyl-1-methoxy-4(1H)-quinolone (HMOQ). HMOQ is a significantly less efficient inhibitor of the respiratory chain cytochromes in Mycobacteria than HQNO and therefore the methylation of HQNO can be seen as detoxification strategy [16].
Considering the natural occurrence of N- as well as O-methylated AQs in plants and the use of methylation of HQNO in Mycobacteria as detoxification reaction, we decided to investigate the effect of methylation of AQs on their biological properties more systematically. To this end, we prepared selectively methylated derivatives of the most important heptyl-AQs including HHQ, HQNO and PQS derivatives. These synthetic compounds were tested for their antimicrobial properties against S. aureus and for their quorum sensing activity.
Results and Discussion
Synthesis of methylated heptyl-AQs
The synthesis of methylated AQ derivatives started from HHQ (1), which is conveniently available via Conrad–Limpach reaction in large quantities [20,21]. Upon treatment of HHQ (1) with n-butyllithium and dimethyl sulfate mainly N-methylation was observed accompanied by a small amount of the N,O-dimethylquinolonium ion. Pure NMe-HHQ (2) was obtained in moderate yield of 51% by column chromatography (Scheme 1).
Selective O-methylation of an AQ has been reported using diazomethane [1]. To avoid explosive diazomethane, methylation of HHQ with trimethylsilyldiazomethane (TMS-DA) in methanol was carried out, which indeed provided selectively OMe-HHQ (3). However, even using a large excess of TMS-DA low conversion and yields of less than 20% OMe-HHQ (3) were observed. Addition of HBF4 did improve the reactivity [22], but instead of the desired 3 dimethylation to give the N,O-dimethylquinolonium ion was observed. Alternatively, HHQ was methylated using MeI and K2CO3[23]. This procedure provided a mixture of O- and N-methylated products with a slight preference for OMe-HHQ (3). OMe-HHQ (3) could be easily separated from the N-methylation product by column chromatography and could be isolated in 32% yield. Surprisingly, the N-methylated product under these conditions was not NMe-HHQ (2), but instead a second methylation in the benzylic position had occurred to give N-methyl-2-(1-methylheptyl)-4(1H)-quinolone (4), which could be isolated in 14% yield.
For the synthesis of methylated HQNO derivatives, HHQ (1) was converted to HQNO (5) using a literature procedure [24], which was slightly modified to provide HQNO in 69% yield over three steps without purification by column chromatography (see Supporting Information File 1 for details). Selective methylation of one of the O-atoms of HQNO was attempted using various methods. Treatment of HQNO (5) in MeOH/Et2O with TMS-DA resulted in selective methylation of the N–O oxygen atom to provide 1-methoxy-2-heptyl-4(1H)-quinolone (HMOQ (6), Scheme 2) [16]. The methylation was highly selective and no methylation at the 4-position oxygen atom was observed, however, conversion and, therefore, yields remained low even with a large excess of reagent. Addition of HBF4 did not improve the yield, but led to side products, which proved to be difficult to remove.
Several attempts were made to obtain the 4-O-methylated HQNO by direct methylation of HQNO (5), however, treatment of HQNO with strong bases such as NaH followed by a methylating agent (MeI) did not provide methylated HQNO derivatives, but complex mixtures containing decomposition products including HHQ (1) and methylated HHQ derivatives. The N–O bond appeared to be unstable under these alkylation conditions. Therefore, the synthesis of the 4-methoxy derivative was carried out starting from OMe-HHQ (3). Upon treatment of 3 with mCPBA the compound was cleanly oxidized to 4OMe-HQNO (7, Scheme 2). Purification by column chromatography provided the highly polar compound 7 in acceptable yield (45%).
Finally, the synthesis of methylated PQS derivatives was carried out. Initially, the direct conversion of OMe-HHQ (3) into 4OMe-PQS (11) was attempted. However, the standard methodology for the conversion of HHQ into PQS such as formylation followed by oxidation failed when applied to OMe-HHQ (3). Alternatively, ortho-metalation next to the methoxy group of OMe-HHQ (3) followed by borylation/oxidation was investigated. Several trials using different lithium bases failed and only small amounts of oxidation products in the benzylic position could be observed. Instead of direct ortho-metalation, a strategy based on halogen–lithium exchange proved to be more suitable. To this end, HHQ (1) was converted into 3I-HHQ (8) following a literature procedure [21]. 3I-HHQ (8) was then methylated using the MeI/K2CO3 conditions to give a mixture of OMe-3I-HHQ (9, 21%) and NMe-3I-HHQ (10, 24%, Scheme 3). Interestingly, in the case of 3I-HHQ (8) the ratio of N-methylation versus O-methylation was almost 1:1 and no further methylation of 10 in the benzylic position was observed. With the methylated compounds 9 and 10 in hand, the halogen-lithium exchange was attempted. Treatment of 9 with n-butyllithium at −78 °C followed by the addition of B(OMe)3 and finally in situ oxidation using sodium perborate provided the desired 4OMe-PQS derivative 11 in moderate yield (35%, Scheme 3). The same procedure could be applied to NMe-3I-HHQ (10), however, the resulting NMe-PQS derivative 12 was only isolated in low yield (14%). Presumably, this compound is not too stable during the final oxidation step as significant amounts of oxidative side products including N-methylisatin were obtained, which also impeded the isolation of the desired product 12. Nevertheless, enough material could be obtained to enable biological investigations on this compound.
Growth inhibition of S. aureus
To get a better understanding of the influence of methylation on the antibiotic properties of AQ compounds, their effect on the growth of S. aureus Newman was investigated (Figure 1). To be able to compare the growth in the presence of the only weakly antibiotic HHQ derivatives, growth experiments were conducted at a concentration of 100 µM. Planktonic cultures of P. aeruginosa in LB medium were reported to contain up to 50 µM PQS and up to 70 µM HQNO [25]. As observed previously, HQNO (5) inhibited the growth of S. aureus significantly, while HHQ (1) had only a moderate effect. Interestingly, the methylated HQNO derivatives 6 and 7 were either equally potent as HQNO or, in the case of 7, even led to a stronger growth reduction. While most of HHQ and PQS derivatives showed no or only very weak effects on the growth of S. aureus, NMe-PQS (12) caused a similar growth inhibition as HQNO. However, the AQs did not significantly affect the formation of static biofilms of S. aureus under the conditions tested (see Figure S1, Supporting Information File 1).
HQNO is known to inhibit complex III of the respiratory chain and therefore leads to a measurable reduction in O2 consumption by cells of S. aureus[16]. The investigation of the O2-consumption rates of S. aureus in response to AQs revealed that among the compounds tested, HQNO (5) had the strongest effect (Figure 2). The 4-O-methylated HHQ and HQNO derivatives 3 and 7, but not the respective PQS derivative 11, also inhibited O2 consumption. In contrast, only weak to moderate inhibition was observed with derivatives methylated either at the nitrogen atom (2, 4 and 12) or at the N–O oxygen atom (6).
Quorum sensing activity
The compounds HHQ, PQS and HQNO are strongly related to quorum sensing and virulence in P. aeruginosa. HHQ and PQS act as signal molecules and, by interacting with the transcriptional regulator PqsR, induce the expression of the AQ biosynthetic genes. Such positive feedback or “auto-induction” loops are considered a hallmark of quorum sensing systems. Therefore, in order to detect potential effects of the methylated AQ derivatives on the AQ-based quorum sensing, we analyzed their influence on the production of PQS and HQNO by P. aeruginosa PAO1 (Figure 3).
For most compounds tested, PQS and HQNO contents of the cultures were unaffected compared to the DMSO control, indicating neither quorum sensing nor antiquorum sensing activity. However, besides the well-known quorum sensing signal molecule HHQ (1), also the two methylated PQS derivatives 11 and 12 and the HQNO derivative 6 elicited PQS and HQNO production by P. aeruginosa PAO1, suggesting quorum sensing activity. However, the significant activity of the HQNO derivative 6 is unexpected, as HQNO is not a signal. We assume that the weak N–O bond is cleaved under the assay conditions and HHQ is generated, which could be the cause of the observed effects. Experiments with a luciferase-based bioreporter strain [26] confirmed that compounds 11 and 12 act via addressing the transcriptional regulator PqsR of the AQ-based quorum sensing system, while compound 6 did not elicit a significant response (see Figure S2, Supporting Information File 1, for details). The data on the PQS derivatives 11 and 12 suggest that the presence of a substituent at one of the heteroatoms does not necessarily preclude quorum sensing activity, and that formation of a 1H-4-oxo-tautomeric form (which is impeded by the O-methylation in 11) is not a prerequisite for quorum sensing activity [27]. Furthermore, in agreement with previous results, our results show the importance of the 3-hydroxy group, which turns non-active compounds 2 and 3 into PQS agonists, irrespective of 4-O-methylation (11) or N-methylation (12) [27-29].
Conclusion
In this study we describe the synthesis of selectively methylated AQs and the influence of methylation on the bioactivity. While the methylation of HHQ is straightforward, selective preparation of methylated HQNO and PQS derivatives required optimized reaction conditions and multistep syntheses. The strategy to “oxidize” the 3-position of AQs via iodination, lithium–halogen exchange and electrophilic trapping can offer a flexible approach to new 3-substituted AQs starting from an easily available synthetic intermediate. While we decided to oxidize the newly formed boronic acid ester in situ, its isolation should be possible and enable further modification, for example by ipso-substitution with heteroatom electrophiles. The application of the boronic acid in Suzuki–Miyaura coupling should also be possible [30,31].
Growth inhibition experiments against S. aureus showed that HQNO derivatives (5, 6 and 7) were generally more efficient than HHQ (1) and its derivatives (2–4 and 8). Interestingly, while PQS and 4OMe-PQS did not have any activity, NMe-PQS (12) was about as active as the HQNO derivatives. The 4-O-methylated derivatives of HQNO (7) and HHQ (3) but not the PQS derivative 11 were shown to reduce O2 consumption similar to HQNO, possibly indicating inhibition of the respiratory chain as proven for HQNO. However, the reduction in O2 consumption is less pronounced for HMOQ (6) and NMe-PQS (12). Therefore, it is possible that growth inhibition is following a different mechanism than for HQNO (5). The investigation of AQ levels in cultures of P. aeruginosa revealed quorum sensing activity for the two PQS derivatives 11 and 12, suggesting once more that AQ-based quorum sensing in P. aeruginosa tolerates significant structural diversity on the signaling molecule [27-29].
Experimental
Detailed synthetic procedures for all new compounds including copies of their NMR spectra can be found in Supporting Information File 1. HHQ and HQNO were prepared by adjusted and optimized literature procedures (see Supporting Information File 1 for details) [20,21]. 3-Iodo-2-heptyl-4(1H)-quinolone (3I-HHQ) was prepared according to a literature procedure [21].
Bioassays
The growth of S. aureus strain Newman in the presence of AQs was followed by measuring the optical density of cell suspensions in 24-well microtiter plates. To this end, freshly grown cells were diluted in LB medium to an OD600 nm of 0.2. Each well contained 1 mL of cell suspension including 100 µM of the AQ derivatives or an equal amount of DMSO. The plates were sealed with optically clear and gas permeable membranes, incubated at 37 °C while shaking and the OD600 nm was measured at certain time points. Experiments were done in biological triplicates (n = 3).
The influence of AQs on the cellular consumption of O2 was studied as previously described [16]. Briefly, exponentially growing cells of S. aureus Newman were diluted in LB to an OD600 nm of 0.5. After adding 100 µM AQs and incubating for 10 min, 500 µL cell suspension was transferred to the chamber of a Clark-type oxygen electrode and the O2 consumption was measured for 2–3 min. Experiments were done in biological triplicates (n = 3).
The effect of AQs on the quorum sensing activity in P. aeruginosa was studied by using AQ biosynthesis as measurable output. The induction of AQ biosynthesis by methylated AQs was followed by measuring PQS and HQNO concentrations in cultures of P. aeruginosa PAO1. Freshly grown cells were diluted to an OD600 nm of 0.2 in LB and supplemented with 100 µM of AQ derivative. After shaking incubation for 4 hours and 24 hours at 37 °C, samples were taken and mixed with two volumes of acidified ethanol (2 g/L citric acid). After pelleting residual cells and debris by centrifugation, samples were analyzed by HPLC to determine PQS and HQNO concentrations [16].
Supporting Information
Supporting Information File 1:
Additional biological data, detailed synthetic procedures and copies of 1H and 13C NMR spectra of all compounds.
Financial support by the DFG (grant FE 383/25-1 to S. F., and Heisenberg grants HE 6020/3-1 and HE 6020/4-1 to U. H.) is gratefully acknowledged. A kind donation of analytical equipment from BASF to U. H. is gratefully acknowledged.
References
Späth, E.; Pikl, J. Ber. Dtsch. Chem. Ges. B1929,62, 2244–2251. doi:10.1002/cber.19290620862
Return to citation in text:
[1]
[2]
[3]
Heeb, S.; Fletcher, M. P.; Chhabra, S. R.; Diggle, S. P.; Williams, P.; Cámara, M. FEMS Microbiol. Rev.2011,35, 247–274. doi:10.1111/j.1574-6976.2010.00247.x
Return to citation in text:
[1]
[2]
[3]
[4]
Diggle, S. P.; Lumjiaktase, P.; Dipilato, F.; Winzer, K.; Kunakorn, M.; Barrett, D. A.; Chhabra, S. R.; Cámara, M.; Williams, P. Chem. Biol.2006,13, 701–710. doi:10.1016/j.chembiol.2006.05.006
Return to citation in text:
[1]
Vial, L.; Lépine, F.; Milot, S.; Groleau, M.-C.; Dekimpe, V.; Woods, D. E.; Déziel, E. J. Bacteriol.2008,190, 5339–5352. doi:10.1128/jb.00400-08
Return to citation in text:
[1]
Long, R. A.; Qureshi, A.; Faulkner, D. J.; Azam, F. Appl. Environ. Microbiol.2003,69, 568–576. doi:10.1128/aem.69.1.568-576.2003
Return to citation in text:
[1]
Hays, E. E.; Wells, I. C.; Katzman, P. A.; Cain, C. K.; Jacobs, F. A.; Thayer, S. A.; Doisy, E. A.; Gaby, W. L.; Roberts, E. C.; Muir, R. D.; Carroll, C. J.; Jones, L. R.; Wade, N. J. J. Biol. Chem.1945,159, 725–750.
Return to citation in text:
[1]
[2]
Wells, I. C. J. Biol. Chem.1952,196, 331–340.
Return to citation in text:
[1]
[2]
Cornforth, J. W.; James, A. T. Biochem. J.1956,63, 124–130. doi:10.1042/bj0630124
Return to citation in text:
[1]
[2]
[3]
Whiteley, M.; Diggle, S. P.; Greenberg, E. P. Nature2017,551, 313–320. doi:10.1038/nature24624
Return to citation in text:
[1]
Ó Muimhneacháin, E.; Reen, F. J.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2018,16, 169–179. doi:10.1039/c7ob02395b
Return to citation in text:
[1]
Pesci, E. C.; Milbank, J. B. J.; Pearson, J. P.; McKnight, S.; Kende, A. S.; Greenberg, E. P.; Iglewski, B. H. Proc. Natl. Acad. Sci. U. S. A.1999,96, 11229–11234. doi:10.1073/pnas.96.20.11229
Return to citation in text:
[1]
[2]
Lightbown, J. W.; Jackson, F. L. Biochem. J.1956,63, 130–137. doi:10.1042/bj0630130
Return to citation in text:
[1]
Filkins, L. M.; Graber, J. A.; Olson, D. G.; Dolben, E. L.; Lynd, L. R.; Bhuju, S.; O'Toole, G. A. J. Bacteriol.2015,197, 2252–2264. doi:10.1128/jb.00059-15
Return to citation in text:
[1]
Thierbach, S.; Birmes, F. S.; Letzel, M. C.; Hennecke, U.; Fetzner, S. ACS Chem. Biol.2017,12, 2305–2312. doi:10.1021/acschembio.7b00345
Return to citation in text:
[1]
[2]
[3]
[4]
[5]
[6]
Bar-On, O.; Mussaffi, H.; Mei-Zahav, M.; Prais, D.; Steuer, G.; Stafler, P.; Hananya, S.; Blau, H. J. Cystic Fibrosis2015,14, 53–62. doi:10.1016/j.jcf.2014.05.008
Return to citation in text:
[1]
Bryant, J. M.; Grogono, D. M.; Rodriguez-Rincon, D.; Everall, I.; Brown, K. P.; Moreno, P.; Verma, D.; Hill, E.; Drijkoningen, J.; Gilligan, P.; Esther, C. R.; Noone, P. G.; Giddings, O.; Bell, S. C.; Thomson, R.; Wainwright, C. E.; Coulter, C.; Pandey, S.; Wood, M. E.; Stockwell, R. E.; Ramsay, K. A.; Sherrard, L. J.; Kidd, T. J.; Jabbour, N.; Johnson, G. R.; Knibbs, L. D.; Morawska, L.; Sly, P. D.; Jones, A.; Bilton, D.; Laurenson, I.; Ruddy, M.; Bourke, S.; Bowler, I. C. J. W.; Chapman, S. J.; Clayton, A.; Cullen, M.; Dempsey, O.; Denton, M.; Desai, M.; Drew, R. J.; Edenborough, F.; Evans, J.; Folb, J.; Daniels, T.; Humphrey, H.; Isalska, B.; Jensen-Fangel, S.; Jönsson, B.; Jones, A. M.; Katzenstein, T. L.; Lillebaek, T.; MacGregor, G.; Mayell, S.; Millar, M.; Modha, D.; Nash, E. F.; O’Brien, C.; O’Brien, D.; Ohri, C.; Pao, C. S.; Peckham, D.; Perrin, F.; Perry, A.; Pressler, T.; Prtak, L.; Qvist, T.; Robb, A.; Rodgers, H.; Schaffer, K.; Shafi, N.; van Ingen, J.; Walshaw, M.; Watson, D.; West, N.; Whitehouse, J.; Haworth, C. S.; Harris, S. R.; Ordway, D.; Parkhill, J.; Floto, R. A. Science2016,354, 751–757. doi:10.1126/science.aaf8156
Return to citation in text:
[1]
Parkins, M. D.; Floto, R. A. J. Cystic Fibrosis2015,14, 293–304. doi:10.1016/j.jcf.2015.03.012
Return to citation in text:
[1]
Reen, F. J.; Clarke, S. L.; Legendre, C.; McSweeney, C. M.; Eccles, K. S.; Lawrence, S. E.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2012,10, 8903–8910. doi:10.1039/c2ob26823j
Return to citation in text:
[1]
[2]
[3]
[4]
Caserio, M. C.; Roberts, J. D.; Neeman, M.; Johnson, W. S. J. Am. Chem. Soc.1958,80, 2584–2585. doi:10.1021/ja01543a056
Return to citation in text:
[1]
Somanathan, R.; Smith, K. M. J. Heterocycl. Chem.1981,18, 1077–1079. doi:10.1002/jhet.5570180603
Return to citation in text:
[1]
Woschek, A.; Mahout, M.; Mereiter, K.; Hammerschmidt, F. Synthesis2007, 1517–1522. doi:10.1055/s-2007-966020
Return to citation in text:
[1]
Lépine, F.; Déziel, E.; Milot, S.; Rahme, L. G. Biochim. Biophys. Acta, Gen. Subj.2003,1622, 36–41. doi:10.1016/s0304-4165(03)00103-x
Return to citation in text:
[1]
Soh, E. Y.-C.; Chhabra, S. R.; Halliday, N.; Heeb, S.; Müller, C.; Birmes, F. S.; Fetzner, S.; Cámara, M.; Chan, K.-G.; Williams, P. Environ. Microbiol.2015,17, 4352–4365. doi:10.1111/1462-2920.12857
Return to citation in text:
[1]
Lu, C.; Kirsch, B.; Maurer, C. K.; de Jong, J. C.; Braunshausen, A.; Steinbach, A.; Hartmann, R. W. Eur. J. Med. Chem.2014,79, 173–183. doi:10.1016/j.ejmech.2014.04.016
Return to citation in text:
[1]
[2]
[3]
Lu, C.; Kirsch, B.; Zimmer, C.; de Jong, J. C.; Henn, C.; Maurer, C. K.; Müsken, M.; Häussler, S.; Steinbach, A.; Hartmann, R. W. Chem. Biol.2012,19, 381–390. doi:10.1016/j.chembiol.2012.01.015
Return to citation in text:
[1]
[2]
Ilangovan, A.; Fletcher, M.; Rampioni, G.; Pustelny, C.; Rumbaugh, K.; Heeb, S.; Cámara, M.; Truman, A.; Chhabra, S. R.; Emsley, J.; Williams, P. PLoS Pathog.2013,9, e1003508. doi:10.1371/journal.ppat.1003508
Return to citation in text:
[1]
[2]
McGlacken, G. P.; McSweeney, C. M.; O’Brien, T.; Lawrence, S. E.; Elcoate, C. J.; Reen, F. J.; O’Gara, F. Tetrahedron Lett.2010,51, 5919–5921. doi:10.1016/j.tetlet.2010.09.013
Return to citation in text:
[1]
Shanahan, R.; Reen, F. J.; Cano, R.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2017,15, 306–310. doi:10.1039/c6ob01930g
Return to citation in text:
[1]
Heeb, S.; Fletcher, M. P.; Chhabra, S. R.; Diggle, S. P.; Williams, P.; Cámara, M. FEMS Microbiol. Rev.2011,35, 247–274. doi:10.1111/j.1574-6976.2010.00247.x
4.
Diggle, S. P.; Lumjiaktase, P.; Dipilato, F.; Winzer, K.; Kunakorn, M.; Barrett, D. A.; Chhabra, S. R.; Cámara, M.; Williams, P. Chem. Biol.2006,13, 701–710. doi:10.1016/j.chembiol.2006.05.006
5.
Vial, L.; Lépine, F.; Milot, S.; Groleau, M.-C.; Dekimpe, V.; Woods, D. E.; Déziel, E. J. Bacteriol.2008,190, 5339–5352. doi:10.1128/jb.00400-08
Hays, E. E.; Wells, I. C.; Katzman, P. A.; Cain, C. K.; Jacobs, F. A.; Thayer, S. A.; Doisy, E. A.; Gaby, W. L.; Roberts, E. C.; Muir, R. D.; Carroll, C. J.; Jones, L. R.; Wade, N. J. J. Biol. Chem.1945,159, 725–750.
Pesci, E. C.; Milbank, J. B. J.; Pearson, J. P.; McKnight, S.; Kende, A. S.; Greenberg, E. P.; Iglewski, B. H. Proc. Natl. Acad. Sci. U. S. A.1999,96, 11229–11234. doi:10.1073/pnas.96.20.11229
Heeb, S.; Fletcher, M. P.; Chhabra, S. R.; Diggle, S. P.; Williams, P.; Cámara, M. FEMS Microbiol. Rev.2011,35, 247–274. doi:10.1111/j.1574-6976.2010.00247.x
10.
Whiteley, M.; Diggle, S. P.; Greenberg, E. P. Nature2017,551, 313–320. doi:10.1038/nature24624
11.
Ó Muimhneacháin, E.; Reen, F. J.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2018,16, 169–179. doi:10.1039/c7ob02395b
12.
Pesci, E. C.; Milbank, J. B. J.; Pearson, J. P.; McKnight, S.; Kende, A. S.; Greenberg, E. P.; Iglewski, B. H. Proc. Natl. Acad. Sci. U. S. A.1999,96, 11229–11234. doi:10.1073/pnas.96.20.11229
Reen, F. J.; Clarke, S. L.; Legendre, C.; McSweeney, C. M.; Eccles, K. S.; Lawrence, S. E.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2012,10, 8903–8910. doi:10.1039/c2ob26823j
Heeb, S.; Fletcher, M. P.; Chhabra, S. R.; Diggle, S. P.; Williams, P.; Cámara, M. FEMS Microbiol. Rev.2011,35, 247–274. doi:10.1111/j.1574-6976.2010.00247.x
7.
Hays, E. E.; Wells, I. C.; Katzman, P. A.; Cain, C. K.; Jacobs, F. A.; Thayer, S. A.; Doisy, E. A.; Gaby, W. L.; Roberts, E. C.; Muir, R. D.; Carroll, C. J.; Jones, L. R.; Wade, N. J. J. Biol. Chem.1945,159, 725–750.
Heeb, S.; Fletcher, M. P.; Chhabra, S. R.; Diggle, S. P.; Williams, P.; Cámara, M. FEMS Microbiol. Rev.2011,35, 247–274. doi:10.1111/j.1574-6976.2010.00247.x
Bar-On, O.; Mussaffi, H.; Mei-Zahav, M.; Prais, D.; Steuer, G.; Stafler, P.; Hananya, S.; Blau, H. J. Cystic Fibrosis2015,14, 53–62. doi:10.1016/j.jcf.2014.05.008
18.
Bryant, J. M.; Grogono, D. M.; Rodriguez-Rincon, D.; Everall, I.; Brown, K. P.; Moreno, P.; Verma, D.; Hill, E.; Drijkoningen, J.; Gilligan, P.; Esther, C. R.; Noone, P. G.; Giddings, O.; Bell, S. C.; Thomson, R.; Wainwright, C. E.; Coulter, C.; Pandey, S.; Wood, M. E.; Stockwell, R. E.; Ramsay, K. A.; Sherrard, L. J.; Kidd, T. J.; Jabbour, N.; Johnson, G. R.; Knibbs, L. D.; Morawska, L.; Sly, P. D.; Jones, A.; Bilton, D.; Laurenson, I.; Ruddy, M.; Bourke, S.; Bowler, I. C. J. W.; Chapman, S. J.; Clayton, A.; Cullen, M.; Dempsey, O.; Denton, M.; Desai, M.; Drew, R. J.; Edenborough, F.; Evans, J.; Folb, J.; Daniels, T.; Humphrey, H.; Isalska, B.; Jensen-Fangel, S.; Jönsson, B.; Jones, A. M.; Katzenstein, T. L.; Lillebaek, T.; MacGregor, G.; Mayell, S.; Millar, M.; Modha, D.; Nash, E. F.; O’Brien, C.; O’Brien, D.; Ohri, C.; Pao, C. S.; Peckham, D.; Perrin, F.; Perry, A.; Pressler, T.; Prtak, L.; Qvist, T.; Robb, A.; Rodgers, H.; Schaffer, K.; Shafi, N.; van Ingen, J.; Walshaw, M.; Watson, D.; West, N.; Whitehouse, J.; Haworth, C. S.; Harris, S. R.; Ordway, D.; Parkhill, J.; Floto, R. A. Science2016,354, 751–757. doi:10.1126/science.aaf8156
Filkins, L. M.; Graber, J. A.; Olson, D. G.; Dolben, E. L.; Lynd, L. R.; Bhuju, S.; O'Toole, G. A. J. Bacteriol.2015,197, 2252–2264. doi:10.1128/jb.00059-15
Reen, F. J.; Clarke, S. L.; Legendre, C.; McSweeney, C. M.; Eccles, K. S.; Lawrence, S. E.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2012,10, 8903–8910. doi:10.1039/c2ob26823j
Reen, F. J.; Clarke, S. L.; Legendre, C.; McSweeney, C. M.; Eccles, K. S.; Lawrence, S. E.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2012,10, 8903–8910. doi:10.1039/c2ob26823j
Reen, F. J.; Clarke, S. L.; Legendre, C.; McSweeney, C. M.; Eccles, K. S.; Lawrence, S. E.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2012,10, 8903–8910. doi:10.1039/c2ob26823j
McGlacken, G. P.; McSweeney, C. M.; O’Brien, T.; Lawrence, S. E.; Elcoate, C. J.; Reen, F. J.; O’Gara, F. Tetrahedron Lett.2010,51, 5919–5921. doi:10.1016/j.tetlet.2010.09.013
31.
Shanahan, R.; Reen, F. J.; Cano, R.; O'Gara, F.; McGlacken, G. P. Org. Biomol. Chem.2017,15, 306–310. doi:10.1039/c6ob01930g
Lu, C.; Kirsch, B.; Maurer, C. K.; de Jong, J. C.; Braunshausen, A.; Steinbach, A.; Hartmann, R. W. Eur. J. Med. Chem.2014,79, 173–183. doi:10.1016/j.ejmech.2014.04.016
28.
Lu, C.; Kirsch, B.; Zimmer, C.; de Jong, J. C.; Henn, C.; Maurer, C. K.; Müsken, M.; Häussler, S.; Steinbach, A.; Hartmann, R. W. Chem. Biol.2012,19, 381–390. doi:10.1016/j.chembiol.2012.01.015
29.
Ilangovan, A.; Fletcher, M.; Rampioni, G.; Pustelny, C.; Rumbaugh, K.; Heeb, S.; Cámara, M.; Truman, A.; Chhabra, S. R.; Emsley, J.; Williams, P. PLoS Pathog.2013,9, e1003508. doi:10.1371/journal.ppat.1003508
Lu, C.; Kirsch, B.; Maurer, C. K.; de Jong, J. C.; Braunshausen, A.; Steinbach, A.; Hartmann, R. W. Eur. J. Med. Chem.2014,79, 173–183. doi:10.1016/j.ejmech.2014.04.016
Lu, C.; Kirsch, B.; Maurer, C. K.; de Jong, J. C.; Braunshausen, A.; Steinbach, A.; Hartmann, R. W. Eur. J. Med. Chem.2014,79, 173–183. doi:10.1016/j.ejmech.2014.04.016
28.
Lu, C.; Kirsch, B.; Zimmer, C.; de Jong, J. C.; Henn, C.; Maurer, C. K.; Müsken, M.; Häussler, S.; Steinbach, A.; Hartmann, R. W. Chem. Biol.2012,19, 381–390. doi:10.1016/j.chembiol.2012.01.015
29.
Ilangovan, A.; Fletcher, M.; Rampioni, G.; Pustelny, C.; Rumbaugh, K.; Heeb, S.; Cámara, M.; Truman, A.; Chhabra, S. R.; Emsley, J.; Williams, P. PLoS Pathog.2013,9, e1003508. doi:10.1371/journal.ppat.1003508